|4Oct 24, 5:57 PM ET

Maccecchini Maria-Luisa 4

4 · Lantern Pharma Inc. · Filed Oct 24, 2022

Insider Transaction Report

Form 4
Period: 2022-10-20
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-10-20+3,2003,200 total
    Exercise: $4.79Exp: 2032-10-19Common Stock (3,200 underlying)
Footnotes (1)
  • [F1]The Option is granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. 356 shares of the Option vested on the day of grant, with the remaining Option shares to vest in equal monthly installments commencing November 8, 2022 with last vesting on June 8, 2025.

Documents

1 file
  • 4
    ownership.xmlPrimary